{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T22:01:16Z","timestamp":1775685676748,"version":"3.50.1"},"reference-count":0,"publisher":"Massachusetts Medical Society","issue":"14","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["N Engl J Med"],"published-print":{"date-parts":[[2026,4,9]]},"DOI":"10.1056\/nejmx250006","type":"journal-article","created":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T21:00:26Z","timestamp":1775682026000},"page":"1456-1456","source":"Crossref","is-referenced-by-count":0,"title":["Daratumumab or Active Monitoring for High-Risk Smoldering Multiple Myeloma"],"prefix":"10.1056","volume":"394","member":"150","container-title":["New England Journal of Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nejm.org\/doi\/pdf\/10.1056\/NEJMx250006","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T21:00:34Z","timestamp":1775682034000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.nejm.org\/doi\/10.1056\/NEJMx250006"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,9]]},"references-count":0,"journal-issue":{"issue":"14","published-print":{"date-parts":[[2026,4,9]]}},"alternative-id":["10.1056\/NEJMx250006"],"URL":"https:\/\/doi.org\/10.1056\/nejmx250006","relation":{},"ISSN":["0028-4793","1533-4406"],"issn-type":[{"value":"0028-4793","type":"print"},{"value":"1533-4406","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,9]]}}}